Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
Macromoltek is a computational drug discovery company dedicated to advancing antibody drug development through strategic partnerships. We design custom antibodies in one week using cutting-edge computational modeling.
Contact us for detailed pricing information tailored to your specific needs and project requirements.
Macromoltek's team comprises experts from various scientific fields, working collaboratively to push the boundaries of antibody design and drug discovery. Our multidisciplinary approach ensures comprehensive solutions to complex problems in antibody development.
We use AI to design antibodies for intractable diseases
Multi-targeted therapeutics to treat complex diseases
Kernal is creating mRNA 2.0 therapies that work in specific cells
Using protein coupling to build new therapies
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS